12X1 fundamentals
An in-depth look to ANAVEX LIFE SCIENC operating, investing, and financing activities
12X1 free cash flow for Q2 24 is -10.52 M CHF. For 2023, 12X1 free cash flow was -25.44 M CHF and operating cash flow was -25.44 M CHF.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM